VNA
RXST icon

Valley National Advisers’s RxSight RXST Stock Holding History

Valley National Advisers’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed -$2K – 1069
2024
Q2 		$2K Hold
35
– – ﹤0.01% 948
2024
Q1 		$1K Hold
35
– – ﹤0.01% 1159
2023
Q4 		$1K Buy
+35
New +$1.03K ﹤0.01% 1134

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Valley National Advisers's RXST Position: Q3 2024 in Review

Valley National Advisers sold out of RxSight (RXST) in Q3 2024, closing a stake of 35 shares — an estimated $2K sold.

Valley National Advisers first reported a position in RXST in Q4 2023 and held it in 3 quarters. The position peaked at $2K in Q2 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Valley National Advisers reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Valley National Advisers sold 35 RxSight shares in Q3 2024, an estimated $2K.
  • Valley National Advisers first reported a position in RxSight in Q4 2023 and held it in 3 quarters.
  • Valley National Advisers's RxSight position peaked at $2K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Valley National Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.